HealthTech Arkansas, in collaboration with MedAxiom, has officially launched the fourth year of its HeartX program, a healthcare accelerator dedicated to advancing cardiovascular innovations.

This initiative, based in Little Rock, Arkansas, aims to support early-stage companies with groundbreaking ideas in cardiovascular care.

The accelerator provides a unique opportunity for these companies to pilot their products with hospitals and participate in clinical trials.

Applications Open for 2025 HeartX Cohort

As of February 1st, applications for the 2025 HeartX cohort are officially open.

The program is set to select five companies by September 2025.

HeartX is looking for startups working in three specific categories: digital health and software, medical devices, and diagnostic platforms.

Companies chosen for the cohort will receive $150,000 in investment capital and, most importantly, will be guaranteed at least one pilot project or clinical study with cardiology practices in Arkansas and beyond.

Supporting Innovation in Cardiovascular Care

HealthTech Arkansas has long been committed to driving innovation within healthcare, particularly through its accelerator programs and internal innovation initiatives.

By partnering with MedAxiom, the program taps into a vast network of experts in cardiovascular care.

MedAxiom works to improve cardiovascular services by leveraging the collective knowledge of thousands of clinicians, administrators, and industry partners across the country.

HeartX Continues to Shape the Future of Cardiovascular Innovation

With the launch of its fourth year, HeartX remains a critical player in shaping the future of cardiovascular care.

By providing funding, access to pilot projects, and the expertise of leading healthcare professionals, the accelerator is helping to bring innovative solutions to market that will ultimately improve patient outcomes and drive advancements in the field.

This article was published on TDPel Media. Thanks for reading!

Share on Facebook «||» Share on Twitter «||» Share on Reddit «||» Share on LinkedIn